Annual Retained Earnings
-$745.50 M
-$160.28 M-27.39%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual retained earnings is -$745.50 million, with the most recent change of -$160.28 million (-27.39%) on December 31, 2023.
- During the last 3 years, AVDL annual retained earnings has fallen by -$361.31 million (-94.05%).
- AVDL annual retained earnings is now -2800.76% below its all-time high of -$25.70 million, reached on December 31, 1996.
Performance
AVDL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$789.28 M
-$2.63 M-0.33%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly retained earnings is -$789.28 million, with the most recent change of -$2.63 million (-0.33%) on September 30, 2024.
- Over the past year, AVDL quarterly retained earnings has dropped by -$43.79 million (-5.87%).
- AVDL quarterly retained earnings is now -3788.10% below its all-time high of -$20.30 million, reached on March 31, 1996.
Performance
AVDL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AVDL Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.4% | -5.9% |
| 3 y3 years | -94.0% | -16.0% |
| 5 y5 years | -108.3% | -16.0% |
AVDL Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.5% | at low | -76.3% | at low |
| 5 y | 5-year | -94.0% | at low | -118.5% | at low |
| alltime | all time | -2800.8% | at low | -3788.1% | at low |
Avadel Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$789.28 M(+0.3%) |
| Jun 2024 | - | -$786.66 M(+1.8%) |
| Mar 2024 | - | -$772.84 M(+3.7%) |
| Dec 2023 | -$745.50 M(+27.4%) | -$745.50 M(+4.0%) |
| Sep 2023 | - | -$716.71 M(+5.3%) |
| Jun 2023 | - | -$680.44 M(+10.5%) |
| Mar 2023 | - | -$616.00 M(+5.3%) |
| Dec 2022 | -$585.22 M(+30.7%) | -$585.22 M(+4.9%) |
| Sep 2022 | - | -$557.77 M(+3.7%) |
| Jun 2022 | - | -$537.62 M(+13.4%) |
| Mar 2022 | - | -$474.18 M(+5.9%) |
| Dec 2021 | -$447.76 M(+16.5%) | -$447.76 M(+5.2%) |
| Sep 2021 | - | -$425.45 M(+5.5%) |
| Jun 2021 | - | -$403.45 M(+5.1%) |
| Mar 2021 | - | -$383.87 M(-0.1%) |
| Dec 2020 | -$384.19 M(-1.8%) | -$384.19 M(+3.0%) |
| Sep 2020 | - | -$372.91 M(+3.2%) |
| Jun 2020 | - | -$361.21 M(-7.9%) |
| Mar 2020 | - | -$392.08 M(+0.2%) |
| Dec 2019 | -$391.21 M(+9.3%) | -$391.21 M(+0.7%) |
| Sep 2019 | - | -$388.48 M(+2.3%) |
| Jun 2019 | - | -$379.61 M(+2.3%) |
| Mar 2019 | - | -$371.01 M(+3.6%) |
| Dec 2018 | -$357.99 M(+36.3%) | -$357.99 M(+21.7%) |
| Sep 2018 | - | -$294.13 M(+5.7%) |
| Jun 2018 | - | -$278.36 M(+1.3%) |
| Mar 2018 | - | -$274.92 M(+4.7%) |
| Dec 2017 | -$262.69 M(-17.9%) | -$262.69 M(+3.2%) |
| Sep 2017 | - | -$254.44 M(-7.9%) |
| Jun 2017 | - | -$276.12 M(-9.5%) |
| Mar 2017 | - | -$305.05 M(-4.6%) |
| Dec 2016 | -$319.80 M(+14.8%) | -$319.80 M(-1.5%) |
| Sep 2016 | - | -$324.53 M(+6.6%) |
| Jun 2016 | - | -$304.54 M(+6.4%) |
| Mar 2016 | - | -$286.17 M(+2.7%) |
| Dec 2015 | -$278.52 M(-13.1%) | -$278.52 M(-14.6%) |
| Jun 2015 | - | -$326.20 M(+5.6%) |
| Mar 2015 | - | -$308.81 M(-3.6%) |
| Dec 2014 | -$320.45 M(+36.0%) | -$320.45 M(+9.3%) |
| Sep 2014 | - | -$293.30 M(+3.5%) |
| Jun 2014 | - | -$283.26 M(+8.0%) |
| Mar 2014 | - | -$262.18 M(+11.3%) |
| Dec 2013 | -$235.55 M(+22.3%) | -$235.55 M(-2.1%) |
| Sep 2013 | - | -$240.67 M(+2.7%) |
| Jun 2013 | - | -$234.30 M(+16.3%) |
| Mar 2013 | - | -$201.45 M(+4.6%) |
| Dec 2012 | -$192.62 M | -$192.62 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | -$195.30 M(+3.1%) |
| Mar 2012 | - | -$189.38 M(-0.0%) |
| Dec 2011 | -$189.39 M(+4.9%) | -$189.39 M(+1.1%) |
| Sep 2011 | - | -$187.30 M(-0.9%) |
| Jun 2011 | - | -$189.00 M(+1.9%) |
| Mar 2011 | - | -$185.55 M(+2.7%) |
| Dec 2010 | -$180.62 M(+5.2%) | -$180.62 M(-1.5%) |
| Sep 2010 | - | -$183.30 M(+1.9%) |
| Jun 2010 | - | -$179.96 M(+2.4%) |
| Mar 2010 | - | -$175.67 M(+2.3%) |
| Dec 2009 | -$171.64 M(+7.1%) | -$171.64 M(+3.4%) |
| Sep 2009 | - | -$165.95 M(+2.1%) |
| Jun 2009 | - | -$162.56 M(+2.2%) |
| Mar 2009 | - | -$159.01 M(-0.7%) |
| Dec 2008 | -$160.21 M(+8.2%) | -$160.21 M(+1.7%) |
| Sep 2008 | - | -$157.48 M(+1.5%) |
| Jun 2008 | - | -$155.18 M(+2.2%) |
| Mar 2008 | - | -$151.82 M(+2.5%) |
| Dec 2007 | -$148.12 M(+34.2%) | -$148.12 M(+4.2%) |
| Sep 2007 | - | -$142.18 M(+6.8%) |
| Jun 2007 | - | -$133.08 M(+11.4%) |
| Mar 2007 | - | -$119.44 M(+8.2%) |
| Dec 2006 | -$110.38 M(+46.8%) | -$110.38 M(+5.6%) |
| Sep 2006 | - | -$104.53 M(+10.8%) |
| Jun 2006 | - | -$94.31 M(+11.2%) |
| Mar 2006 | - | -$84.84 M(+12.8%) |
| Dec 2005 | -$75.18 M(+57.3%) | -$75.18 M(+9.4%) |
| Sep 2005 | - | -$68.73 M(+20.9%) |
| Jun 2005 | - | -$56.85 M(+19.3%) |
| Mar 2005 | - | -$47.66 M(-0.3%) |
| Dec 2004 | -$47.81 M(-20.2%) | -$47.81 M(-16.3%) |
| Sep 2004 | - | -$57.13 M(0.0%) |
| Jun 2004 | - | -$57.13 M(+2.8%) |
| Mar 2004 | - | -$55.58 M(-7.2%) |
| Dec 2003 | -$59.88 M(+6.2%) | -$59.88 M(-2.8%) |
| Sep 2003 | - | -$61.57 M(+3.1%) |
| Jun 2003 | - | -$59.70 M(+2.8%) |
| Mar 2003 | - | -$58.05 M(+3.0%) |
| Dec 2002 | -$56.38 M(-5.1%) | -$56.38 M(+0.6%) |
| Sep 2002 | - | -$56.05 M(-5.6%) |
| Dec 2001 | -$59.39 M(+5.1%) | -$59.39 M(+5.1%) |
| Dec 2000 | -$56.51 M(+20.1%) | -$56.51 M(+20.1%) |
| Dec 1999 | -$47.05 M(+16.6%) | -$47.05 M(+16.6%) |
| Dec 1998 | -$40.36 M(+24.2%) | -$40.36 M(+15.3%) |
| Mar 1998 | - | -$35.00 M(+7.7%) |
| Dec 1997 | -$32.50 M(+26.5%) | -$32.50 M(+26.5%) |
| Dec 1996 | -$25.70 M | -$25.70 M(+26.6%) |
| Mar 1996 | - | -$20.30 M |
FAQ
- What is Avadel Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual retained earnings year-on-year change?
- What is Avadel Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly retained earnings year-on-year change?
What is Avadel Pharmaceuticals annual retained earnings?
The current annual retained earnings of AVDL is -$745.50 M
What is the all time high annual retained earnings for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual retained earnings is -$25.70 M
What is Avadel Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, AVDL annual retained earnings has changed by -$160.28 M (-27.39%)
What is Avadel Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of AVDL is -$789.28 M
What is the all time high quarterly retained earnings for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly retained earnings is -$20.30 M
What is Avadel Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, AVDL quarterly retained earnings has changed by -$43.79 M (-5.87%)